![Antioxidants | Free Full-Text | Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment Antioxidants | Free Full-Text | Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment](https://www.mdpi.com/antioxidants/antioxidants-09-00207/article_deploy/html/images/antioxidants-09-00207-g001.png)
Antioxidants | Free Full-Text | Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
![Antioxidants | Free Full-Text | Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma Antioxidants | Free Full-Text | Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma](https://pub.mdpi-res.com/antioxidants/antioxidants-12-00529/article_deploy/html/images/antioxidants-12-00529-g001.png?1676882188)
Antioxidants | Free Full-Text | Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma
![Antioxidants | Free Full-Text | Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment Antioxidants | Free Full-Text | Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment](https://www.mdpi.com/antioxidants/antioxidants-09-00207/article_deploy/html/images/antioxidants-09-00207-g003.png)